However, full vaccination associated with two-thirds lower risk for death with cirrhosis
Pharmacists Effectively Administered Passive Immunizations Too
During the recent pandemic, the U.S. government authorized the expansion of the scope of pharmacy practice. An often-mentioned success story is the number of COVID-19 vaccinations administrated by pharmacists to senior citizens.
A second, less-known success was the safe and effective delivery of monoclonal antibodies (mAbs) in a community pharmacy.
Old Tuberculosis Vaccine Gets Energized
While versions of the Bacille Calmette-Guerin (BCG) vaccine have been used successfully for decades, researchers have pursued newer vaccines based on innovative technologies.
MMRV Vaccines Gain Intramuscular Administration Authorization
A global leader in children's vaccines today announced an additional administration route approved by the U.S. Food and Drug Administration (FDA).
Merck confirmed on March 6, 2023, the FDA had approved the addition of the intramuscular (IM) route of administration to the United States Product Insert for Merck's M-M-R®II, VARIVAX®, and ProQuad® vaccines.
Merck says these are the only measles, mumps, rubella, and varicella vaccines that can be administered IM.
These vaccines have already been licensed for IM administration in the European Union.
One in Four Parents Nonadherent to COVID-19 Public Health Measures
Most common reasons included wanting to exercise personal freedom as a parent, wanting child’s life to feel normal
More Travelers Enjoy Shorter Airport Security Wait Times
The U.S. Transportation Security Administration (TSA) recently announced two indications the travel industry has recovered from the multi-year pandemic.
On March 3, 2023, the TSA PreCheck® application program surpassed 15 million active members, setting a new record that began in December 2013.
Thirty-two million travelers now benefit from TSA PreCheck expedited airport security screening after being vetted through TSA PreCheck ®, U.S. Customs and Border Protection's Global Entry, or another federal vetting program.
Kentucky's Measles Cases Cause Concern
The Centers for Disease Control and Prevention (CDC) today issued a Health Alert Network (HAN) Health Advisory to notify clinicians and public health officials about a confirmed measles case in Kentucky (KY).
On February 24, 2023, the Kentucky Department for Public Health (KDPH) identified a confirmed case of measles in an unvaccinated Jessamine County, Kentucky resident.
While infectious, the resident, with a history of recent international travel, attended Asbury University's services in Hughes Auditorium in Wilmore, KY, on February 18, 2023.
South Africa's Measles Outbreak Migrates North
Since the measles outbreak began in October 2022, various Republic of South Africa (RSA) provinces have been impacted. However, recent data announced by the National Institute for Communicable Diseases indicates most new measles cases are confirmed in the north.
As of March 2023, a measles outbreak has been declared in the Northern Cape Province in the Francis Baard district.
Specifically, 13 specimens from Limpopo and North West Province had measles virus genotype D8 sequences related to the Zimbabwe 2022 measles outbreak strain.
$30 Million Funding Advances Marburg and Sudan Virus Vaccines
IAVI announced today that the U.S. Biomedical Advanced Research and Development Authority (BARDA) funded additional development and testing of single-dose vaccine candidates against the filoviruses Marburg virus (MARV) and Sudan ebolavirus (SUDV).
BARDA's US$30 million award to the nonprofit IAVI on March 2, 2023, expands the agency's existing support of SUDV vaccine candidate (rVSVΔG-SUDV-GP) development.
The new BARDA funding empowers IAVI and partners to advance the rVSVΔG-SUDV-GP development plan to include a Phase I clinical trial in the United States in 2023.
Two Bird Flu Cases in Cambodia Did Not Spread Person to Person
The 11-year-old girl and her father both got the virus from poultry, international health authorities say